Nel ASA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nel ASA with three other
miscellaneous service companies in Europe:
BB Biotech AG
sales of 12.16 million Swiss Francs [US$12.27 million]
of which 100%
was Investing & Related Activity),
GW Pharmaceuticals PLC
of the United Kingdom
(£10.32 million [US$12.86 million]
of which 63%
was Commercial), and
based in France
(11.20 million Euro [US$12.09 million]
Nel ASA reported sales of NOK 114.48 million (US$13.47 million)
December of 2016.
increase of 14.6%
versus 2015, when the company's sales were NOK 99.93 million.
This was the fourth straight year of sales growth at Nel ASA.